Ignite Creation Date:
2024-05-06 @ 7:06 AM
Last Modification Date:
2024-10-26 @ 11:45 AM
Study NCT ID:
NCT02477670
Status:
COMPLETED
Last Update Posted:
2020-09-16
First Post:
2015-06-18
Brief Title:
Efficacy Safety and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia
Sponsor:
Avanir Pharmaceuticals
Organization:
Avanir Pharmaceuticals